Photographic Evidence of Oral Precancerous Lesions in Current Tobacco and Areca Nut Users Improves Their Quit Rates

Sponsor
All India Institute of Medical Sciences, New Delhi (Other)
Overall Status
Completed
CT.gov ID
NCT05215860
Collaborator
(none)
200
1
2
12.9
15.5

Study Details

Study Description

Brief Summary

The success of tobacco and areca nut cessation programs in individuals with Oral Potentially Malignant Disorders (OPMDs) is imperative for risk reduction and prevention of oral cancer. A prospective pilot interventional study where 200 participants with current tobacco and areca nut habits and OPMD were randomly divided in two groups. Group A ( n=100; Habit cessation counselling with general and medical management for OPMD). Group B ( n=100; Habit cessation counselling with general and medical management for OPMD and visual exposure to personal intraoral photographs of oral lesions at baseline and review).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Tobacco and areca nut cessation counselling with standard management for Oral Potentially Malignant Disorders
  • Other: visual exposure to personal intraoral photographs of oral lesions at baseline and review
N/A

Detailed Description

A prospective pilot interventional study was carried out in a Oral Medicine unit at a tertiary referral center where OPMD and Oral cancer screening is carried out routinely in all patients examined in the Out Patient Department (OPD). Ethical clearance for conducting the study and taking serial intraoral photographs of OPMD in consenting participants was obtained from the Institute Ethics Committee.All patients in OPD were initially screened for current habits of any form of tobacco and areca nut products through history and referred to the Tobacco Cessation Clinic (TCC) for individual counselling session.This counselling was based on the toolkit issued by the World Health Organization (WHO) for delivering brief tobacco intervention under WHO capacity building training package.The patients then underwent detailed intraoral examination for any oral mucosal changes. Those patients that were diagnosed as having any OPMD as per clinical diagnostic criteria were then recruited as participants in the study. A total of 200 participants with current tobacco and areca nut habits and OPMDs were recruited after informed written consent and randomly assigned to the two groups. The Control Group A had 100 participants who received standard management protocol for OPMD. The experimental Group B received all the management as in Control Group A but were also shown their intraoral photographs of oral lesions and explained about the areas of abnormalities that were of concern. All the participants were reviewed at 1, 3 and 6 months for surveillance of OPMD lesions and habit status.The data was analysed for statistically significant differences between the two groups p<0.05.

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A prospective pilot interventional longitudinal studyA prospective pilot interventional longitudinal study
Masking:
Single (Investigator)
Masking Description:
The investigator who provided behavioural counselling to the participants was blinded to their clinical diagnosis of oral lesions
Primary Purpose:
Prevention
Official Title:
Visual Communication Through Personal Intraoral Photographs of Oral Potentially Malignant Disorders in Current Tobacco and Areca Nut Users Improves Habit Abstinence: a Pilot Interventional Study
Actual Study Start Date :
Sep 1, 2020
Actual Primary Completion Date :
Sep 30, 2021
Actual Study Completion Date :
Sep 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Habit cessation counselling with management for OPMD

n=100; Habit cessation counselling with general and medical management for OPMD

Behavioral: Tobacco and areca nut cessation counselling with standard management for Oral Potentially Malignant Disorders
WHO toolkit for Tobacco cessation (5A's and 5R's model)

Experimental: Habit cessation counselling, management for OPMD and intraoral photographs

n=100; Habit cessation counselling with standard management for OPMD and visual exposure to personal intraoral photographs of oral lesions at baseline and review

Behavioral: Tobacco and areca nut cessation counselling with standard management for Oral Potentially Malignant Disorders
WHO toolkit for Tobacco cessation (5A's and 5R's model)

Other: visual exposure to personal intraoral photographs of oral lesions at baseline and review
Chairside digital intraoral photographs of oral potentially malignant disorder with smart phone and showing the photograph to the participant explaining the abnormal areas of concern

Outcome Measures

Primary Outcome Measures

  1. Habit quit rates [6 months]

    Discontinuation of habit more than 1 month.

Secondary Outcome Measures

  1. Size of oral lesions [6 months]

    Change in size of lesions from baseline in millimeters

  2. Oral burning sensation [6 months]

    Change in oral burning sensation from baseline Visual Analogue Scale (VAS) scale 0-10; 0: No oral burning sensation; 10: Worst oral burning sensation

  3. Colour of oral lesions [6 months]

    Change in colour of oral lesions from red to white

  4. Inter incisal mouth opening [6 months]

    Change in interincisal mouth opening from baseline in millimeters

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Current tobacco and areca nut users.

  • Presence of oral potentially malignant disorders

Exclusion Criteria:

• Any oral lesion suspicious of malignancy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oral Medicine and Radiology, CDER, AIIMS New Delhi Delhi India 100029

Sponsors and Collaborators

  • All India Institute of Medical Sciences, New Delhi

Investigators

  • Principal Investigator: Shalini Gupta, MDS,FDSRCS, All India Institute of Medical Sciences, New Delhi

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Shalini Gupta, Additional Professor, All India Institute of Medical Sciences, New Delhi
ClinicalTrials.gov Identifier:
NCT05215860
Other Study ID Numbers:
  • IEC-616
First Posted:
Jan 31, 2022
Last Update Posted:
Feb 11, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. Shalini Gupta, Additional Professor, All India Institute of Medical Sciences, New Delhi
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 11, 2022